1. Home
  2. SCPH vs FSP Comparison

SCPH vs FSP Comparison

Compare SCPH & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • FSP
  • Stock Information
  • Founded
  • SCPH 2013
  • FSP 1981
  • Country
  • SCPH United States
  • FSP United States
  • Employees
  • SCPH N/A
  • FSP N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • FSP Real Estate Investment Trusts
  • Sector
  • SCPH Health Care
  • FSP Real Estate
  • Exchange
  • SCPH Nasdaq
  • FSP Nasdaq
  • Market Cap
  • SCPH 173.6M
  • FSP 187.5M
  • IPO Year
  • SCPH 2017
  • FSP N/A
  • Fundamental
  • Price
  • SCPH $2.78
  • FSP $1.85
  • Analyst Decision
  • SCPH Strong Buy
  • FSP
  • Analyst Count
  • SCPH 3
  • FSP 0
  • Target Price
  • SCPH $14.00
  • FSP N/A
  • AVG Volume (30 Days)
  • SCPH 629.3K
  • FSP 382.9K
  • Earning Date
  • SCPH 03-19-2025
  • FSP 04-29-2025
  • Dividend Yield
  • SCPH N/A
  • FSP 2.19%
  • EPS Growth
  • SCPH N/A
  • FSP N/A
  • EPS
  • SCPH N/A
  • FSP N/A
  • Revenue
  • SCPH $36,332,000.00
  • FSP $120,112,000.00
  • Revenue This Year
  • SCPH $134.20
  • FSP $4.36
  • Revenue Next Year
  • SCPH $99.40
  • FSP $0.81
  • P/E Ratio
  • SCPH N/A
  • FSP N/A
  • Revenue Growth
  • SCPH 167.28
  • FSP N/A
  • 52 Week Low
  • SCPH $2.72
  • FSP $1.47
  • 52 Week High
  • SCPH $5.65
  • FSP $2.31
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 34.45
  • FSP 51.78
  • Support Level
  • SCPH $2.87
  • FSP $1.76
  • Resistance Level
  • SCPH $3.08
  • FSP $1.93
  • Average True Range (ATR)
  • SCPH 0.18
  • FSP 0.07
  • MACD
  • SCPH -0.00
  • FSP 0.01
  • Stochastic Oscillator
  • SCPH 11.70
  • FSP 61.90

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

Share on Social Networks: